Clinical Immunology and Immunopathology
Volume 5, Issue 1, January 1976, Pages 48-59
Lymphokine properties of a lymphoid cultured cell supernatant fraction active in promoting tumor regression☆
References (34)
- et al.
Clin. Immunol. Immunopathol.
(1976) - et al.
Blood
(1966) - et al.
J. Med. (Cincinnati)
(1975) - et al.
Res. Commun. Chem. Pathol. Pharmacol.
(1974) - et al.
- et al.
Amer. J. Pathol.
(1970) - et al.
J. Immunol.
(1970)
J. Exp. Med.
(1971)
J. Immunol.
(1972)
J. Exp. Med.
(1972)
J. Immunol.
(1973)
Clin. Immunol. Immunopathol.
(1976)
Cited by (22)
Cellular origin of human lymphotoxin and its purification
1985, Clinical Immunology and ImmunopathologyUtilization of purified human monocytes in the agarose droplet assay for measuring migration inhibitory factors
1983, Journal of Immunological MethodsLymphokine-stimulated macrophage phagocytosis of fluorescent microspheres: a rapid new assay
1983, Journal of Immunological MethodsStatistically designed assay of migration-inhibitory activity in lymphokine preparations
1981, ImmunopharmacologyBiological characterization of guinea pig lymphotoxin production
1979, Immunopharmacology
- ☆
These studies were supported in part by funds from the Cancer Research Institute, Inc., New York; Hematology Research Fund, Mercy Catholic Hospital; The University of Texas; and NIH DHEW Grant No. 5S01 RR05427(12).
- 2
At the time these studies were performed, Steven Parmett, formerly an undergraduate student at Harvard College, and Dennis Dobkin, formerly an undergraduate student at the University of Rochester, were NSF Summer Fellows at Roswell Park Memorial Institute, Buffalo, N.Y. Present addresses: S. Parmett, Harvard Medical School, Boston, Mass., and D. Dobkin, SUNY Medical School, Syracuse, N.Y.
Copyright © 1976 Published by Elsevier Inc.